BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29191447)

  • 1. Comparative evidence on harms in pediatric randomized clinical trials from less developed versus more developed countries is limited.
    Tedesco D; Farid-Kapadia M; Offringa M; Bhutta ZA; Maldonado Y; Ioannidis JPA; Contopoulos-Ioannidis DG
    J Clin Epidemiol; 2018 Mar; 95():63-72. PubMed ID: 29191447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative rates of harms in randomized trials from more developed versus less developed countries may be different.
    Contopoulos-Ioannidis D; Tseretopoulou X; Ancker M; Walterspiel JN; Panagiotou OA; Maldonado Y; Ioannidis JP
    J Clin Epidemiol; 2016 Oct; 78():10-21. PubMed ID: 27063207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of medical interventions in children versus adults.
    Lathyris D; Panagiotou OA; Baltogianni M; Ioannidis JP; Contopoulos-Ioannidis DG
    Pediatrics; 2014 Mar; 133(3):e666-73. PubMed ID: 24567023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of nuisance parameters in pediatric versus adult randomized trials: a meta-epidemiologic empirical evaluation.
    Vandermeer B; van der Tweel I; Jansen-van der Weide MC; Weinreich SS; Contopoulos-Ioannidis DG; Bassler D; Fernandes RM; Askie L; Saloojee H; Baiardi P; Ellenberg SS; van der Lee JH
    BMC Med Res Methodol; 2018 Jan; 18(1):7. PubMed ID: 29321002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness of medical interventions in adults versus children.
    Contopoulos-Ioannidis DG; Baltogianni MS; Ioannidis JP
    J Pediatr; 2010 Aug; 157(2):322-330.e17. PubMed ID: 20434730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harms reported by patients in rheumatology drug trials: a systematic review of randomized trials in the cochrane library from an OMERACT working group.
    Berthelsen DB; Woodworth TG; Goel N; Ioannidis JPA; Tugwell P; Devoe D; Williamson P; Terwee CB; Suarez-Almazor ME; Strand V; Leong AL; Conaghan PG; Boers M; Shea BJ; Brooks PM; Simon LS; Furst DE; Christensen R;
    Semin Arthritis Rheum; 2021 Jun; 51(3):607-617. PubMed ID: 33483129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study.
    Dechartres A; Boutron I; Trinquart L; Charles P; Ravaud P
    Ann Intern Med; 2011 Jul; 155(1):39-51. PubMed ID: 21727292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empirical evaluation of age groups and age-subgroup analyses in pediatric randomized trials and pediatric meta-analyses.
    Contopoulos-Ioannidis DG; Seto I; Hamm MP; Thomson D; Hartling L; Ioannidis JP; Curtis S; Constantin E; Batmanabane G; Klassen T; Williams K
    Pediatrics; 2012 Jun; 129 Suppl 3():S161-84. PubMed ID: 22661763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No consistent evidence of data availability bias existed in recent individual participant data meta-analyses: a meta-epidemiological study.
    Tsujimoto Y; Fujii T; Onishi A; Omae K; Luo Y; Imai H; Takahashi S; Itaya T; Pinson C; Nevitt SJ; Furukawa TA
    J Clin Epidemiol; 2020 Feb; 118():107-114.e5. PubMed ID: 31654789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of fibrin sealant during non-emergency surgery: a systematic review of evidence of benefits and harms.
    Edwards SJ; Crawford F; van Velthoven MH; Berardi A; Osei-Assibey G; Bacelar M; Salih F; Wakefield V
    Health Technol Assess; 2016 Dec; 20(94):1-224. PubMed ID: 28051764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity subgroup analysis based on single-center vs. multi-center trial status when interpreting meta-analyses pooled estimates: the logical way forward.
    Alexander PE; Bonner AJ; Agarwal A; Li SA; Hariharan A; Izhar Z; Bhatnagar N; Alba C; Akl EA; Fei Y; Guyatt GH; Beyene J
    J Clin Epidemiol; 2016 Jun; 74():80-92. PubMed ID: 26597972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between analytic strategy and estimates of treatment outcomes in meta-analyses.
    Dechartres A; Altman DG; Trinquart L; Boutron I; Ravaud P
    JAMA; 2014 Aug; 312(6):623-30. PubMed ID: 25117131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview.
    Golder S; Loke YK; Bland M
    PLoS Med; 2011 May; 8(5):e1001026. PubMed ID: 21559325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effect sizes in randomised trials from less developed and more developed countries: meta-epidemiological assessment.
    Panagiotou OA; Contopoulos-Ioannidis DG; Ioannidis JP
    BMJ; 2013 Feb; 346():f707. PubMed ID: 23403829
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.